Osteoclastogenesis inhibitory factor (OCIF) /OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases)
Tsuda, E.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 679-687
2002
ISSN/ISBN: 0047-1852 PMID: 11979969 Document Number: 546644
Document emailed within 1 workday
Related Documents
Rizzoli, R. 2009: Metabolic bone diseases: benefits and risks of the treatment Revue Medicale Suisse 5(207): 1299-1300Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336
Tatarchenko, I.P.; Komarova, E.V. 2008: Idiopathic calcified aorta stenosis and the relation with disturbance in bone metabolic diseases: new approaches to pathogenesis and treatment Klinicheskaia Meditsina 86(7): 4-7
Yoshikawa, S. 1986: Etiology and pathology of metabolic bone diseases: Paget's disease of bone and osteosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2437-2442
Grompe, M. 1999: Therapeutic liver repopulation for the treatment of metabolic liver diseases Human Cell 12(4): 171-180
Morimoto, Y. 1986: Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2391-2398
Im, C.H.; Kang, E.H.; Ki, J.Y.; Shin, D.W.; Choi, H.J.; Chang, E.J.; Lee, E.Y.; Lee, Y.J.; Lee, E.B.; Kim, H.H.; Song, Y.W. 2009: Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis Clinical and Experimental Rheumatology 27(4): 620-625
Juji, T.; Tanaka, S. 2004: Novel therapeutic approach to bone metabolic disorders using RANKL vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 799-802
Yamauchi, M.; Sugimoto, T. 2019: Wnt signaling and bone metabolic diseases Clinical Calcium 29(3): 329-336
Sugimura, K.; Ohno, T.; Fukuda, S.; Wada, Y.; Kimura, T.; Azuma, I. 1990: Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor Cancer Research 50(2): 345-349
Shiraki, M. 1986: Metabolic bone diseases: osteomalacia due to Fe or Al poisoning Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2493-2498
Parkman, R. 1993: Bone marrow transplantation for immunodeficiency and metabolic diseases Leukemia 7(7): 1100-1102
Barbagallo, M. 1987: Histo-morphometry of the bone in metabolic diseases of the bones Recenti Progressi in Medicina 78(12): 566-570
Ogura, Y.; Aizawa, S.; Oda, Y. 1986: Metabolic bone diseases: renal tubular acidosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2499-2506
Nakamura, T.; Kurokawa, T. 1986: Etiology and pathology of metabolic bone diseases: osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2409-2416
Takeuchi, Y. 2006: Metabolic bone diseases in patients with diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 64(9): 1697-1702
Yumita, S.; Furukawa, Y. 1986: Etiology and pathology of metabolic bone diseases: osteitis fibrosa Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2422-2427
Popova, I.P.; Fedortsova, L.P.; Sheviakova, L.V.; Beiul YeA 1989: Excess body weight at a young age as a risk factor for developing metabolic diseases Voprosy Pitaniia 1: 13-15
Oguchi, S. 1987: X-ray photodensitometric study of the second metacarpal--a new method of evaluation of metabolic bone diseases Nihon Seikeigeka Gakkai Zasshi 61(12): 1389-1404
Lin, J.S.; Kao, J.T.; Tsai, K.S. 1996: Type I collagen and procollagen fragments in patients with metabolic bone diseases Journal of the Formosan Medical Association 95(7): 523-529